Oversight Challenges In The Medicare Prescription Drug Program
Location: Dirksen Senate Office Building SD-342
Open in New Window
Member Statements
-
Chairman Thomas R. Carper D (DE)Sen Carper Opening Statement 3.3.10 (782k)
-
Senator John McCain R (AZ)3.3.10 Sen McCain Opening (522k)
Witnesses
Panel 1
-
Ms. Kathleen KingKing Testimony 3.3.10 (2464k)Director, Health CareU.S. Government Accountability Office
-
Mr. Robert VitoVito Testimony 3.3.10 NEW (1562k)Regional Inspector General for Evaluations and InspectionsOffice of the Inspector General, U.S. Department of Health and Human Services
-
Mr. Jonathan BlumBlum Testimony 3.3.10 (2695k)Director, Center for Drug and Health Plan ChoiceU.S. Department of Health and Human Services
Panel 2
-
Mr. Howard AppleApple Testimony 3.3.10 (1050k)PresidentSafeguard Services, LLC
-
Dr. Christian JensenJensen Testimony 3.3.10 (1070k)President and Cheif Executive OfficerHealth Integrity, LLC